WallStreetZenWallStreetZen

NASDAQ: KOD
Kodiak Sciences Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for KOD

Based on 7 analysts offering 12 month price targets for Kodiak Sciences Inc.
Min Forecast
$6.00-19.57%
Avg Forecast
$18.14+143.2%
Max Forecast
$50.00+570.24%

Should I buy or sell KOD stock?

Based on 7 analysts offering ratings for Kodiak Sciences Inc.
Hold
Strong Buy
2 analysts 28.57%
Buy
0 analysts 0%
Hold
3 analysts 42.86%
Sell
0 analysts 0%
Strong Sell
2 analysts 28.57%

Be the first to know when Wall Street analysts revise their KOD stock forecasts and price targets.

KOD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Bottom 3%
3
HoldMaintains$9.00+23.46%2022-11-14
Goldman Sachs
Top 14%
87
HoldMaintains$8.00+9.74%2022-11-10
Chardan Capital
Bottom 20%
20
Strong BuyMaintains$18.00+146.91%2022-08-10
Truist Securities
Bottom 11%
11
Strong BuyMaintains$15.00+105.76%2022-08-09
Citigroup
Top 6%
95
Strong SellDowngrades$6.00-17.70%2022-08-02
Anonymous
Goldman Sachs
HoldMaintains$5.00-31.41%2022-05-24
JP Morgan
Bottom 2%
2
HoldDowngrades$21.00+188.07%2022-02-24
Barclays
Top 17%
84
Strong SellMaintains$50.00+585.87%2022-02-07

1 of 1

Forecast return on equity

Is KOD forecast to generate an efficient return?
Company
-36.43%
Industry
14.69%
Market
64.75%
KOD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is KOD forecast to generate an efficient return on assets?
Company
-24.13%
Industry
13.16%
KOD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KOD earnings per share forecast

What is KOD's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$7.12
Avg 2 year Forecast
-$5.04
Avg 3 year Forecast
-$5.04

KOD revenue forecast

What is KOD's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$201.8M
Avg 2 year Forecast
$9.4M
Avg 3 year Forecast
$14.7M

KOD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KOD$7.29$18.14+148.88%Hold
CNTA$4.01$6.67+66.26%Hold
PTGX$7.80$29.75+281.41%Strong Buy
PGEN$1.82$9.00+394.51%Strong Buy
ETNB$8.26$24.00+190.56%Strong Buy

Kodiak Sciences Stock Forecast FAQ

Is Kodiak Sciences Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: KOD) stock is to Hold KOD stock.

Out of 7 analysts, 2 (28.57%) are recommending KOD as a Strong Buy, 0 (0%) are recommending KOD as a Buy, 3 (42.86%) are recommending KOD as a Hold, 0 (0%) are recommending KOD as a Sell, and 2 (28.57%) are recommending KOD as a Strong Sell.

If you're new to stock investing, here's how to buy Kodiak Sciences stock.

What is KOD's earnings growth forecast for 2022-2024?

(NASDAQ: KOD) Kodiak Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.86%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.96%.

Kodiak Sciences's earnings in 2022 is -$356,540,000.On average, 5 Wall Street analysts forecast KOD's earnings for 2022 to be -$372,441,176, with the lowest KOD earnings forecast at -$391,272,472, and the highest KOD earnings forecast at -$356,748,430. On average, 5 Wall Street analysts forecast KOD's earnings for 2023 to be -$263,638,136, with the lowest KOD earnings forecast at -$404,872,852, and the highest KOD earnings forecast at -$156,927,462.

In 2024, KOD is forecast to generate -$263,638,136 in earnings, with the lowest earnings forecast at -$402,780,486 and the highest earnings forecast at -$184,651,314.

What is KOD's revenue growth forecast for 2022-2024?

(NASDAQ: KOD) Kodiak Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.76%.

Kodiak Sciences's revenue in 2022 is $0.On average, 1 Wall Street analysts forecast KOD's revenue for 2022 to be $10,556,510,369, with the lowest KOD revenue forecast at $10,556,510,369, and the highest KOD revenue forecast at $10,556,510,369. On average, 1 Wall Street analysts forecast KOD's revenue for 2023 to be $491,182,956, with the lowest KOD revenue forecast at $491,182,956, and the highest KOD revenue forecast at $491,182,956.

In 2024, KOD is forecast to generate $767,113,743 in revenue, with the lowest revenue forecast at $732,328,156 and the highest revenue forecast at $801,899,331.

What is KOD's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: KOD) forecast ROA is -24.13%, which is lower than the forecast US Biotechnology industry average of 13.16%.

What is KOD's Price Target?

According to 7 Wall Street analysts that have issued a 1 year KOD price target, the average KOD price target is $18.14, with the highest KOD stock price forecast at $50.00 and the lowest KOD stock price forecast at $6.00.

On average, Wall Street analysts predict that Kodiak Sciences's share price could reach $18.14 by Nov 14, 2023. The average Kodiak Sciences stock price prediction forecasts a potential upside of 148.88% from the current KOD share price of $7.29.

What is KOD's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: KOD) Kodiak Sciences's current Earnings Per Share (EPS) is -$6.84. On average, analysts forecast that KOD's EPS will be -$7.12 for 2022, with the lowest EPS forecast at -$7.48, and the highest EPS forecast at -$6.82. On average, analysts forecast that KOD's EPS will be -$5.04 for 2023, with the lowest EPS forecast at -$7.74, and the highest EPS forecast at -$3.00. In 2024, KOD's EPS is forecast to hit -$5.04 (min: -$7.70, max: -$3.53).

What is KOD's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: KOD) forecast ROE is -36.43%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.